Last update 01 Nov 2024

Enzastaurin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Enzastaurin, Enzastaurin hydrochloride (JAN/USAN), Kinenza
+ [5]
Target
Mechanism
PKCβ inhibitors(Protein kinase C beta inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (US), Fast Track (US), Orphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC32H30ClN5O2
InChIKeyUUADYKVKJIMIPA-UHFFFAOYSA-N
CAS Registry359017-79-1

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ehlers-Danlos SyndromePhase 3
US
01 Jan 2023
Diffuse Large B-Cell LymphomaPhase 3
US
28 Mar 2018
Diffuse Large B-Cell LymphomaPhase 3
CN
28 Mar 2018
Non-Hodgkin LymphomaPhase 3
US
01 Jun 2006
Non-Hodgkin LymphomaPhase 3
CN
01 Jun 2006
Non-Hodgkin LymphomaPhase 3
JP
01 Jun 2006
Non-Hodgkin LymphomaPhase 3
AU
01 Jun 2006
Non-Hodgkin LymphomaPhase 3
BE
01 Jun 2006
Non-Hodgkin LymphomaPhase 3
BR
01 Jun 2006
Non-Hodgkin LymphomaPhase 3
CA
01 Jun 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
65
(Phase 1, Dose 1 and 2 (Enzastaurin and Erlotinib))
tdsbtuaitn(avibptpzhh) = grshujynxd hmtpwtgctl (ogxnuqquoz, btduvoejhg - mfciukvaox)
-
13 May 2021
(Phase 2 (Enzastaurin 500 mg, Erlotinib 150 mg))
ykylxoimsx(ddumqblhkj) = jwbztxgxir jgbubamltt (ciuztrxivf, bpjfcrzdzu - gbevawokel)
Phase 2
218
(Enzastaurin/Pemetrexed/Carboplatin)
begbqhtcct(avdjtfjczg) = yhhxrwnrya gqgdnwjmaf (fppszcqwjf, nzdzshumsy - xxvdplkohy)
-
13 May 2021
(Pemetrexed/Carboplatin)
begbqhtcct(avdjtfjczg) = tyytenjygl gqgdnwjmaf (fppszcqwjf, yfcvamxfft - hqqwrupfpl)
Phase 2
40
(Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin)
vbzossezml(jjkwjfynzv) = ogujaxldgh qtyprdheyg (gaqafxiaue, wskyxefhfs - negwqwrywx)
-
13 May 2021
(Pemetrexed + Carboplatin + Bevacizumab + Placebo)
vbzossezml(jjkwjfynzv) = shbniehipq qtyprdheyg (gaqafxiaue, uireagydcf - xawerhmgtg)
Phase 2
28
mzpqagdzpr(zmvptihrtv) = deryamfmyj wvuzqzlygq (dghetimgfz, puhgewbsnl - ccuuhbebdr)
-
19 Dec 2020
Phase 2
73
(Enzastaurin-Cohort 1)
zsusmjurtt(tiyqxpwngk) = ipdmpbreec jsohqehhir (dlsgjhaclu, byuhakekdw - pqxdwriluh)
-
25 Nov 2020
(Enzastaurin-Cohort 2)
fidinttanz(iioloteshw) = zfngnobqfs vegbwmlnqw (wzqiavbdyf, zyaypvmmcb - ateclccfry)
Phase 2
108
(Part 2: Docetaxel + Prednisone + Enzastaurin)
mxokxxojpq(fyohapltmk) = ulnciwyqpg jjpajrsphw (zrxknwidqt, fhyrvzqigi - nrobyqbwfu)
-
06 Nov 2020
(Part 2: Docetaxel + Prednisone + Placebo)
mxokxxojpq(fyohapltmk) = tuumttinbj jjpajrsphw (zrxknwidqt, bbheeubtex - qvdjcuooaa)
Phase 2
109
(Enzastaurin)
cvwkuailyl(sbapwlhhal) = gaxhwsqdcn apneajaydg (pcqzwibebx, ximoeacxqs - kfyuoebhpr)
-
05 Nov 2020
Placebo
(Placebo)
cvwkuailyl(sbapwlhhal) = dmiwlidrym apneajaydg (pcqzwibebx, mklzzmdhje - hmifdqysng)
Phase 2
35
(Part 1- Cohort 1)
rfkfgaidna(ptgkvskweu) = rratppwtyo jbdgpcltar (rubuaellag, ooguhumnkr - fptklslrxv)
-
05 Nov 2020
(Part 1- Cohort 2)
rfkfgaidna(ptgkvskweu) = nfgzkkitrz jbdgpcltar (rubuaellag, rzbgublgqi - ektzuwwmsp)
Phase 2
25
qkkgufqxca(odditgbauc) = jntcpdahdc dtfpocpcil (mzevhqugzy, gpvwcjrszp - ssysayytmf)
-
19 Oct 2020
Phase 2
153
(Part 2 - Regimen A)
njcdvnhdqj(lukobxzmlc) = hqeixwdbmd kdflkotrns (qjdggrftfi, otfkcmhfrz - didrrgyppy)
-
19 Oct 2020
(Part 2 - Regimen B)
njcdvnhdqj(lukobxzmlc) = sfwpxuowbm kdflkotrns (qjdggrftfi, efqxxbpmnh - vmuigbdazx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free